Significance and Function of HGAL in Lymphoma
Significance and Function of HGAL in Lymphoma
批准号:
8270507
负责人:
IZIDORE S LOSSOS
金额:
$24.32万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2014-05-31
关键词:
ActinsActomyosinAffectAntigensAtypical lymphocyteB-Cell Lymphoma 6 ProteinB-LymphocytesBehaviorBindingBiologicalBiological MarkersBiological ProcessBiologyC-terminalCell CommunicationCell Differentiation processCell Migration Inhibition functionCell physiologyCellsCharacteristicsClinicalCloningComplexCytoskeletonDataDevelopmentDiagnosisDiseaseEnvironmentExpressed Sequence TagsFamilyFilopodiaFundingGene Expression ProfilingGenesGoalsGrantHistocompatibility Antigens Class IIHodgkin DiseaseHumanImmune responseInterleukin-6KnowledgeLaboratoriesLeadLymphocyteLymphocyte BiologyLymphomaLymphomagenesisMalignant - descriptorMediatingMediator of activation proteinMolecularMolecular TargetMotorMyosin ATPaseMyosin Regulatory Light ChainsMyosin Type IIN-terminalNeoplasm MetastasisNon-Hodgkin&aposs LymphomaOutcomePathogenesisPathologic ProcessesPatientsPhosphorylationPhysiologicalPhysiological ProcessesPlayPredispositionProcessPrognostic MarkerProteinsReactionReagentRegulationResearchRoleSiteStructureStructure of germinal center of lymph nodeTestingTimeTissuesTransgenic MiceTumor ImmunityTyrosineWound Healingabstractingangiogenesisbasecancer therapycell mediated immune responsecell motilitygene cloningimprovedin vivolarge cell Diffuse non-Hodgkin&aposs lymphomalymphoid neoplasmmalignant lymphocytemembermigrationmouse modelmyristoylationneoplastic cellnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsoutcome forecastoverexpressionpreventprognosticresponserho GTP-Binding ProteinsrhoA GTP-Binding Proteintooltreatment strategytumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
This project is based on our findings that high expression of Human Germinal center Associated Lymphoma
(HGAL) - a new gene that we cloned and characterized - is an independent predictor of prolonged survival of
diffuse large B cell lymphoma (DLBCL) and Hodgkin's disease (HD) patients. Recently, we demonstrated that
HGAL mediates IL-6-induced inhibition of germinal center (GC) B-cell migration. We demonstrated that IL-6
induces Lyn-mediated phosphorylation of the HGAL C-terminal tyrosine and causes HGAL relocalization to
podosome-like structures and spike-like filopodia. We showed interactions between endogenous HGAL and
myosin II and delineated HGAL domains responsible for the interaction. We provided evidence that HGAL
phosphorylation results in increased interaction with the myosin II and demonstrated that knockdown of
endogenous HGAL ameliorates the inhibitory effects of the IL-6 on cell migration. Taken together, these results
identified HGAL as a physiological mediator of IL-6 effects on lymphocyte migration and suggest that HGAL
expression in GC-derived lymphomas may limit tumor dissemination and predispose to better clinical outcome.
However, despite the marked progress in identifying HGAL role in cellular processes, the precise mechanisms
of HGAL-mediated inhibition of cell migration and consequent predisposition to better clinical outcome of
tumors expressing HGAL are presently unknown. Our preliminary data demonstrates that HGAL may affect cell
motility by interacting with myosin II and/or by increasing RoA activity. However, these effects need to be
further investigated. In this project we will: 1) Determine effects of HGAL on myosin II function; 2) Determine
effects of HGAL on a member of the small Rho GTPase family - RhoA protein and its effectors; 3) Determine
the role of HGAL myristoylation and palmytoylation on its inhibitory effects on cell motility; and 4) Determine
the effects of HGAL expression in transgenic mice model on lymphocyte differentiation, maturation, motility and
lymphomagenesis. These studies will expand our knowledge on biology of the GC lymphocytes, with specific
emphasis on lymphocyte motility and migration. Furthermore, these studies will reveal potentially new
mechanisms regulating dissemination and progression of lymphoid tumors. These mechanistic studies may
provide novel approaches for new therapeutic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
-
批准号:9900766
-
项目类别:
-
资助金额:$35.95万
-
财政年份:2019
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
-
批准号:10378494
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2019
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
-
批准号:10599232
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2019
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Prognostic Models in Diffuse Large B-Cell Lymphoma
-
批准号:7676701
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2007
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Prognostic Models in Diffuse Large B-Cell Lymphoma
-
批准号:7379862
-
项目类别:
-
资助金额:$39.58万
-
财政年份:2007
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Prognostic Models in Diffuse Large B-Cell Lymphoma
-
批准号:7500654
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2007
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Prognostic Models in Diffuse Large B-Cell Lymphoma
-
批准号:7880670
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2007
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:8054687
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:7046800
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:6918441
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:8463466
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:7893249
-
项目类别:
-
资助金额:$25.07万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:7193468
-
项目类别:
-
资助金额:$25.53万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:7729298
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
Significance and Function of HGAL in Lymphoma
-
批准号:8078185
-
项目类别:
-
资助金额:$24.32万
-
财政年份:2005
-
负责人:IZIDORE S LOSSOS
-
依托单位:
国内基金
海外基金
由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
-
批准号:82360313
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:滕藤
-
依托单位: